Innovations in Seizure Management: Exploring New Antiseizure Medications and Targeted Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 2266
Special Issue Editors
Interests: neurology; epilepsy; neurogenetic
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Epilepsy treatment has undergone notable advancements owing to novel pharmacological approaches and targeted therapies, spanning across age groups from adults to children. This shift towards precision medicine aims to tackle the diverse etiologies of epilepsy and individual patient responses. By emphasizing personalized treatment strategies such as therapeutic drug monitoring and the integration of pharmacogenomic data, clinicians can optimize therapy efficacy and safety.
This Special Issue of IJMS will focus on the recent developments in pharmacological treatments for epilepsy, highlighting the potential of targeted therapy to revolutionize patient care. By targeting the specific molecular pathways underlying seizure disorders, these therapies offer promising avenues for seizure control and an enhanced quality of life. Additionally, the incorporation of precision medicine principles into clinical practice has the potential of tailoring treatment regimens, minimizing adverse reactions, and optimizing therapeutic outcomes.
Furthermore, epilepsy encompasses various medical conditions characterized by recurrent seizures, presenting a management challenge due to the plethora of syndromes, seizure types, and variable treatment responses among individuals. Over the past two decades, genetic etiology has been unveiled in over half of all epilepsies, with single gene defects in ion channels or neurotransmitter receptors associated with the most inherited forms. The advent of genetic tests, ranging from targeted assays to whole exome and whole genome sequencing, has propelled genetic discovery in epilepsy, shedding light on molecular mechanisms and providing targets for precision medicine in select syndromes. While precision medicine in epilepsy has primarily focused on seizure control, addressing neurodevelopmental and neuropsychiatric comorbidities remains a future avenue. This Special Issue aims to explore the recent advances in genetic testing and outline the tailored treatments applicable to some monogenic epilepsies, envisioning a future where epilepsy treatment adopts a widespread precision medicine approach.
Dr. Antonio Gennaro Nicotera
Prof. Dr. Gabriella Di Rosa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiseizure medications
- targeted therapies
- epilepsy
- monogenic epilepsies
- new antiseizures medications
- developmental and epileptic encephalopathies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
